Key facts
- It has raised $577K across 1 recorded rounds; the latest was Seed Round ($577K) in Nov 2022.
- Notable investors include ADIT Ventures.
- Statera Biopharma has filed 1 Form D with the SEC, most recently Nov 2022 ($577K sold to 12 investors).
Investors
1Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Statera Biopharma
Create free account
No card required
Funding rounds
1 roundsAbout Statera Biopharma
PA Mark — not yet priced
Statera Biopharma doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Statera Biopharma shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Statera Biopharma in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.